Stay updated on Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial

Sign up to get notified when there's something new on the Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Added a new revision note: Revision: v3.3.3. The footer/links were updated by removing 'HHS Vulnerability Disclosure' and the older 'Revision: v3.3.2'.
    Difference
    0.2%
    Check dated 2025-12-23T22:07:41.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    A new version entry (v3.3.2) was added to the Study Record Versions, and the old entry (v3.2.0) was removed.
    Difference
    0.1%
    Check dated 2025-11-25T11:22:21.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding is now displayed, indicating that the information on the site may not be up to date and transactions may not be processed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2025-11-18T07:00:55.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Version 8 (2024-10-09) adds new sections such as Document Section, Participant Flow, Baseline Characteristics, Outcome Measures (Results), Adverse Events, and Limitations and Caveats, and updates multiple areas including Study Identification, Study Status, Study Description, Arms and Interventions, and Contacts/Locations.
    Difference
    0.1%
    Check dated 2025-11-03T21:08:23.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    - Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.
    Difference
    11%
    Check dated 2025-10-06T05:48:07.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-29T03:09:46.000Z thumbnail image

Stay in the know with updates to Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial page.